Sharon G. Adler

机构：UCLA Medical Center, Harbor–UCLA Medical Center · ORCID：0000-0002-0247-3878

发表论文 243 篇 · 总被引 21568 次 · h-index 64

代表论文

• KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases (2021 · Kidney International · 被引 2541)
• Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases (2021 · Kidney International · 被引 822)
• Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial (2023 · The Lancet · 被引 301)
• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial (2023 · The Lancet · 被引 226)
• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis (2022 · Diabetes Care · 被引 215)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 102)